Torrent Pharma's stock reaches all-time high following positive Q4 results leading to optimistic outlook from brokerages.

Torrent Pharmaceuticals' stock price increased by 7% on May 27, reaching an all-time high of Rs 2,795 per share as investors reacted positively to the company's impressive Q4FY24 performance and promising future growth prospects. Additionally, optimistic forecasts for the company's growth, as described by numerous brokerages, also enhanced positive attitudes.

At the same time, Torrent's management is also anticipating positive growth in the future, aiming to achieve a strong overall performance in fiscal year 2025. Management anticipates maintaining double-digit growth in the branded generics markets of India and Brazil, with Germany projected to achieve an 8 percent year-on-year growth thanks to new tenders and launches.

Additionally, the company's performance in the US market is anticipated to improve because of new product launches and compliance being restored at its Dahej facility, leading to growth.